United States Drugs for Malaria Market Report & Forecast 2021-2027

United States Drugs for Malaria Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Drugs for Malaria Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Drugs for Malaria Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Drugs for Malaria Overall Market Size
2.1 United States Drugs for Malaria Market Size: 2021 VS 2027
2.2 United States Drugs for Malaria Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Malaria Players in United States Market
3.2 Top United States Drugs for Malaria Companies Ranked by Revenue
3.3 United States Drugs for Malaria Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Malaria Companies in United States Market, by Revenue in 2020
3.5 Companies Drugs for Malaria Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Malaria Players in United States Market
3.6.1 List of Tier 1 Drugs for Malaria Companies in United States
3.6.2 List of Tier 2 and Tier 3 Drugs for Malaria Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Drugs for Malaria Market Size Markets, 2021 & 2027
4.1.2 Aryl Aminoalcohol Compounds
4.1.3 Antifolate Compounds
4.1.4 Artemisinin Compounds
4.2 By Type - United States Drugs for Malaria Revenue & Forecasts
4.2.1 By Type - United States Drugs for Malaria Revenue, 2016-2021
4.2.2 By Type - United States Drugs for Malaria Revenue, 2022-2027
4.2.3 By Type - United States Drugs for Malaria Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Drugs for Malaria Market Size, 2021 & 2027
5.1.2 Prevention
5.1.3 Treatment
5.1.4 Others
5.2 By Application - United States Drugs for Malaria Revenue & Forecasts
5.2.1 By Application - United States Drugs for Malaria Revenue, 2016-2021
5.2.2 By Application - United States Drugs for Malaria Revenue, 2022-2027
5.2.3 By Application - United States Drugs for Malaria Revenue Market Share, 2016-2027
6 Drugs for Malaria Companies Profiles
6.1 Cipla
6.1.1 Cipla Company Details
6.1.2 Cipla Business Overview
6.1.3 Cipla Drugs for Malaria Introduction
6.1.4 Cipla Drugs for Malaria Revenue in United States Market (2016-2021)
6.1.5 Cipla Recent Developments
6.2 Guilin Pharmaceutical
6.2.1 Guilin Pharmaceutical Company Details
6.2.2 Guilin Pharmaceutical Business Overview
6.2.3 Guilin Pharmaceutical Drugs for Malaria Introduction
6.2.4 Guilin Pharmaceutical Drugs for Malaria Revenue in United States Market (2016-2021)
6.2.5 Guilin Pharmaceutical Recent Developments
6.3 IPCA Laboratories
6.3.1 IPCA Laboratories Company Details
6.3.2 IPCA Laboratories Business Overview
6.3.3 IPCA Laboratories Drugs for Malaria Introduction
6.3.4 IPCA Laboratories Drugs for Malaria Revenue in United States Market (2016-2021)
6.3.5 IPCA Laboratories Recent Developments
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Company Details
6.4.2 GlaxoSmithKline Business Overview
6.4.3 GlaxoSmithKline Drugs for Malaria Introduction
6.4.4 GlaxoSmithKline Drugs for Malaria Revenue in United States Market (2016-2021)
6.4.5 GlaxoSmithKline Recent Developments
6.5 Mylan Labs
6.5.1 Mylan Labs Company Details
6.5.2 Mylan Labs Business Overview
6.5.3 Mylan Labs Drugs for Malaria Introduction
6.5.4 Mylan Labs Drugs for Malaria Revenue in United States Market (2016-2021)
6.5.5 Mylan Labs Recent Developments
6.6 Roche
6.6.1 Roche Company Details
6.6.2 Roche Business Overview
6.6.3 Roche Drugs for Malaria Introduction
6.6.4 Roche Drugs for Malaria Revenue in United States Market (2016-2021)
6.6.5 Roche Recent Developments
6.7 Novartis
6.7.1 Novartis Company Details
6.7.2 Novartis Business Overview
6.7.3 Novartis Drugs for Malaria Introduction
6.7.4 Novartis Drugs for Malaria Revenue in United States Market (2016-2021)
6.7.5 Novartis Recent Developments
6.8 Sanofi Aventis
6.8.1 Sanofi Aventis Company Details
6.8.2 Sanofi Aventis Business Overview
6.8.3 Sanofi Aventis Drugs for Malaria Introduction
6.8.4 Sanofi Aventis Drugs for Malaria Revenue in United States Market (2016-2021)
6.8.5 Sanofi Aventis Recent Developments
6.9 Ajanta Pharma
6.9.1 Ajanta Pharma Company Details
6.9.2 Ajanta Pharma Business Overview
6.9.3 Ajanta Pharma Drugs for Malaria Introduction
6.9.4 Ajanta Pharma Drugs for Malaria Revenue in United States Market (2016-2021)
6.9.5 Ajanta Pharma Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Drugs for Malaria Market Opportunities & Trends in United States Market
Table 2. Drugs for Malaria Market Drivers in United States Market
Table 3. Drugs for Malaria Market Restraints in United States Market
Table 4. Key Players of Drugs for Malaria in United States Market
Table 5. Top Drugs for Malaria Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Drugs for Malaria Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Drugs for Malaria Revenue Share by Companies, 2016-2021
Table 8. Companies Drugs for Malaria Product Type
Table 9. List of Tier 1 Drugs for Malaria Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Drugs for Malaria Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Drugs for Malaria Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Drugs for Malaria Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Drugs for Malaria Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Drugs for Malaria Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Drugs for Malaria Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Drugs for Malaria Revenue (US$, Mn), 2022-2027
Table 17. Cipla Company Details
Table 18. Cipla Business Overview
Table 19. Cipla Drugs for Malaria Product
Table 20. Cipla Drugs for Malaria Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Cipla Recent Developments
Table 22. Guilin Pharmaceutical Company Details
Table 23. Guilin Pharmaceutical Business Overview
Table 24. Guilin Pharmaceutical Drugs for Malaria Product
Table 25. Guilin Pharmaceutical Drugs for Malaria Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Guilin Pharmaceutical Recent Developments
Table 27. IPCA Laboratories Company Details
Table 28. IPCA Laboratories Business Overview
Table 29. IPCA Laboratories Drugs for Malaria Product
Table 30. IPCA Laboratories Drugs for Malaria Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. IPCA Laboratories Recent Developments
Table 32. GlaxoSmithKline Company Details
Table 33. GlaxoSmithKline Business Overview
Table 34. GlaxoSmithKline Drugs for Malaria Product
Table 35. GlaxoSmithKline Drugs for Malaria Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. GlaxoSmithKline Recent Developments
Table 37. Mylan Labs Company Details
Table 38. Mylan Labs Business Overview
Table 39. Mylan Labs Drugs for Malaria Product
Table 40. Mylan Labs Drugs for Malaria Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Mylan Labs Recent Developments
Table 42. Roche Company Details
Table 43. Roche Business Overview
Table 44. Roche Drugs for Malaria Product
Table 45. Roche Drugs for Malaria Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Roche Recent Developments
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Drugs for Malaria Product
Table 50. Novartis Drugs for Malaria Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Novartis Recent Developments
Table 52. Sanofi Aventis Company Details
Table 53. Sanofi Aventis Business Overview
Table 54. Sanofi Aventis Drugs for Malaria Product
Table 55. Sanofi Aventis Drugs for Malaria Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Sanofi Aventis Recent Developments
Table 57. Ajanta Pharma Company Details
Table 58. Ajanta Pharma Business Overview
Table 59. Ajanta Pharma Drugs for Malaria Product
Table 60. Ajanta Pharma Drugs for Malaria Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Ajanta Pharma Recent Developments
List of Figures
Figure 1. Drugs for Malaria Segment by Type
Figure 2. Drugs for Malaria Segment by Application
Figure 3. United States Drugs for Malaria Market Overview: 2020
Figure 4. United States Drugs for Malaria Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Drugs for Malaria Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Drugs for Malaria Revenue in 2020
Figure 7. By Type - United States Drugs for Malaria Revenue Market Share, 2016-2027
Figure 8. By Application - United States Drugs for Malaria Revenue Market Share, 2016-2027
Figure 9. Cipla Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Guilin Pharmaceutical Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. IPCA Laboratories Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. GlaxoSmithKline Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Mylan Labs Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Roche Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Novartis Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Sanofi Aventis Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Ajanta Pharma Drugs for Malaria Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Dihydroartemisinin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88

The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2......

Global Artemisinin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Artemisinin market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinin is forecast to a readjusted size of US$ 227 million by 2030 with a CAGR of 20.7% during review period. The research report highlights the growth potential of the global Artemisinin market. Artemisinin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Drugs for Malaria Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Drugs for Malaria market size was valued at US$ million in 2023. With growing demand in downstream market, the Drugs for Malaria is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Drugs for Malaria market. Drugs for Malaria are expected to show stable growth in the future market. However, product differentiation, reduc......

Dihydroartemisinin - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 99

The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Global Drugs For Malaria Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Drugs For Malaria market: According to our latest research, the global Drugs For Malaria market looks promising in the next 5 years. As of 2022, the global Drugs For Malaria market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. It is Anti-malarial drug. Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to ......

Global Artemisinin Professional Survey Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 105

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Artemisinin Market Research Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 131

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Dihydroartemisinin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Dihydroartemisinin market: According to our latest research, the global Dihydroartemisinin market looks promising in the next 5 years. As of 2022, the global Dihydroartemisinin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dihydroartemisini......

Global Artemisinin Market Insights, Forecast to 2029

Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 108

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast. The global Artemisinin market is projected to grow from US$ 75 million in 2023 to US$ 225.3 million by 2029, at a Compound Annual Growth Rate......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs